米国FDAが主導する「プロジェクト・オプティマス」とは？
がん治療薬開発にどのような影響を与えるのか？
がん治療薬開発にどのような影響を与えるのか？
Project Optimus is an initiative proposed by the U.S. Food and Drug Administration’s Oncology Center…
Certara2022年2月2日
Choosing an eCTD Submissions Vendor: Your Complete Checklist
Selecting the right electronic submission services vendor for your organization’s regulatory submissions to health authorities…
Certara2022年1月28日
Don’t Forget About Safety! How to Assess Drug Candidate Safety in Early Clinical Development
This blog will reflect on 3 things drug developers should pay attention to regarding safety…
Certara2022年1月24日
規制申請のためにeCTDベンダーを選定するのはいつが適切ですか？
As your company moves towards the regulatory submission of a marketing application to a health…
Certara2022年1月10日
A Bird’s Eye View on Rare Diseases: Key Drug Development Considerations for Thyroid Eye Disease
New therapeutics discovery and development for ocular diseases have been traditionally associated with a low…
Certara2021年12月15日
Industry Metrics for CDISC Controlled Terminology
Sergiy Sirichenko summarizes industry metrics across many studies and sponsors to produce an overall picture…
Certara2021年11月17日
Developing Targeted Covalent Inhibitor Drugs: 3 Key Considerations
Traditional mechanisms of drug action rely on the reversible, noncovalent interaction of a ligand with…
Certara2021年11月5日
Accelerating ADCs’ development pipeline using Simcyp PBPK
With nearly 10 million deaths in 2020 and despite great progress, cancer remains the leading…
Certara2021年10月15日
A Day in the Life of a Clinical Pharmacology Consultant
Strategic consulting within drug discovery and development is an exciting career choice for many. Unlike…
Certara2021年10月8日
Building a Robust Clinical Pharmacology & Model-Informed Drug Development Strategy for New Alzheimer’s Disease Drugs
Alzheimer's disease (AD) is one of the most common forms of neurodegenerative dementia in the…
Certara2021年9月20日
